Clinical Significance of Ryanodine Receptor-1 (RYR-1) Gene Variants: New Insights Into Pathophysiology, Diagnosis and Treatment of RYR1-Linked Diseases
November 1-2, 2013
This conference is in honor of Dr. David MacLennan for his contributions to our understanding of the genetics, pathogenesis and treatment of MH.
Summary/Abstract: Through lectures and interactive discussions with subject matter experts in molecular genetic diagnosis, and muscle function in health and disease, this project will inform physicians and scientists who are researching malignant hyperthermia (MH) and its variants and those who care for patients with MH, heat stroke and muscle breakdown of the latest advances in the field. Sharing this information will advance genetic diagnosis of patients suspected of being at risk for MH, congenital muscle disorders, heat stroke and muscle breakdown with exercise.
Information regarding full agenda of topics to be covered, hotel options, ground transportation, things to do, and more can be found on the MHAUS website at www.mhaus.org, via the link http://my.mhaus.org/group/sciconf13.
Contact MHAUS for further clarification and insight by calling (800) 986-4287 or email firstname.lastname@example.org.
Topics covered will not be found anywhere else and will prove to be eye-opening and insightful. All speakers are well known in their field of expertise. Sign up soon via the MHAUS website; registrations are limited and will be on a first come-first serve basis.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of UPSTATE Medical University and MHAUS. UPSTATE Medical University is accredited by the ACCME to provide continuing medical education for physicians.
UPSTATE Medical University designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physician should claim only the credit commensurate with the extent of their participation in the activity.